Zacks Investment Research
17 Apr 2026, 17:11 UTC · 23w ago
Verdict
Headline leans bullish. We score IART +0.80 across three claims.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+0.80strongly bullish
What the story claims
3 claims · scored −1 bearish … +1 bullish
Integra LifeSciences (IART) has reported a positive average earnings surprise of 15.32% over the last two quarters.
So whatA consistent track record of beating earnings estimates typically increases investor confidence in management's ability to deliver results.
More positive than 67% of claims this week
Integra LifeSciences currently has a positive Zacks Earnings ESP of 0.82%, indicating that analyst estimates have been revised upward.
Continue reading
5 related stories
More positive than 89% of ticker scores this week
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More positive than 55% of claims this week
Integra LifeSciences holds a Zacks Rank #3 (Hold).
Near neutral — 99% of claims this week are stronger
Which stocks this story touches
More positive than 89% of ticker scores this week
The company has a record of beating earnings estimates and a positive Earnings ESP, suggesting bullish near-term potential.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
53m ago
+49.4%
Price agrees with the score
$16.20 vs $10.84 close before publication (Apr 16) · not market-adjusted
IART chart →
